關鍵數據
2.230今開
2.555最高
304.77K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.40%換手率
2.150昨收
1.910最低
664.17K成交額
虧損本益比靜
8.86市淨率
0.00%股息率 TTM
-27.84%ROA
3.44052週最高
0.11量比
-43.71M淨利潤
76.20M總股本
-0.5402每股盈餘TTM
1.07Beta
-152.36%ROE
0.80052週最低
30.00%振幅
50.23%毛利率
166.12M總市值
9.89回報/風險
7.42%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Neuronetics Inc評分
-0.06與上次評分對比預測8.50
財務診斷6.58
技術分析5.62
公司估值8.72
機構認同度5.00
風險評估2.47
分析師評級
買入評級
5.750目標均價
+155.56%漲幅空間
Neuronetics Inc 最新財報電話會記錄
Neuronetics (STIM) 2026年第三季法說會:利潤率擴張與正向EBITDA
Neuronetics 2026年第三季財報電話會議:營收成長12.5%至4,200萬美元,毛利率達52.2%,全年財測指引維持在1.6億至1.64億美元。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Neuronetics Inc 簡介
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.
行業醫療設備與耗材
公司代碼STIM
員工數量716
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Madryn Asset Management, LP | 29.80% |
|---|
| Chernett (Jorey) | 14.34% |
|---|
| Parian Ultreia LP | 6.96% |
|---|
| UBS Financial Services, Inc. | 4.13% |
|---|
| 股東類型 | 佔比 |
|---|
| Private Equity | 29.80% |
|---|
| Individual Investor | 24.40% |
|---|
| Investment Advisor | 17.45% |
|---|
| Hedge Fund | 10.25% |
|---|
常見問題
Neuronetics Inc(STIM)的當前股價是多少?
Neuronetics Inc(STIM)的當前股價是 2.15。
Neuronetics Inc 的股票代碼是什麼?
Neuronetics Inc的股票代碼是STIM。
Neuronetics Inc股票的52週最高點是多少?
Neuronetics Inc股票的52週最高點是3.44。
Neuronetics Inc股票的52週最低點是多少?
Neuronetics Inc股票的52週最低點是0.80。
Neuronetics Inc的市值是163.83M。
現在Neuronetics Inc(STIM)的股票是買入、持有還是賣出?
根據分析師評級,Neuronetics Inc(STIM)的總體評級為買入,目標價格為5.75。
Neuronetics Inc(STIM)股票的每股收益(EPS TTM)是多少
Neuronetics Inc(STIM)股票的每股收益(EPS TTM)是-0.54。